Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
FEBS Open Bio ; 12(1): 295-305, 2022 01.
Article in English | MEDLINE | ID: mdl-34854258

ABSTRACT

Declines in mitochondrial functions are associated with aging. The combination of 5-aminolevulinic acid (5-ALA) and sodium ferrous citrate (SFC) improves mitochondrial functions in cultured cells. In this study, we investigated the effects of dietary supplementation with 5-ALA and SFC (5-ALA/SFC) on the healthspan and life span of Drosophila melanogaster. Adult Drosophila fruit flies were fed cornmeal food containing various concentrations of 5-ALA/SFC. Locomotor functions, life span, muscle architecture, and age-associated changes in mitochondrial function were analyzed. We found that feeding 5-ALA/SFC mitigated age-associated declines in locomotor functions and extended organismal life span. Moreover, 5-ALA/SFC preserved muscle architecture and maintained the mitochondrial membrane potential in aged animals. Since 5-ALA phosphate/SFC is used as a human dietary supplement, our results suggest that it could be used to slow the age-related declines in muscle functions, prevent age-associated clinical conditions such as frailty, and extend healthspan and life span.


Subject(s)
Aminolevulinic Acid , Drosophila , Aminolevulinic Acid/pharmacology , Animals , Citric Acid , Drosophila melanogaster , Ferrous Compounds , Muscles
2.
PLoS One ; 8(1): e53706, 2013.
Article in English | MEDLINE | ID: mdl-23349732

ABSTRACT

The senescence marker protein-30 (SMP30), which is also called regucalcin, exhibits gluconolactonase (GNL) activity. Biochemical and biological analyses revealed that SMP30/GNL catalyzes formation of the γ-lactone-ring of L-gulonate in the ascorbic acid biosynthesis pathway. The molecular basis of the γ-lactone formation, however, remains elusive due to the lack of structural information on SMP30/GNL in complex with its substrate. Here, we report the crystal structures of mouse SMP30/GNL and its complex with xylitol, a substrate analogue, and those with 1,5-anhydro-D-glucitol and D-glucose, product analogues. Comparison of the crystal structure of mouse SMP30/GNL with other related enzymes has revealed unique characteristics of mouse SMP30/GNL. First, the substrate-binding pocket of mouse SMP30/GNL is designed to specifically recognize monosaccharide molecules. The divalent metal ion in the active site and polar residues lining the substrate-binding cavity interact with hydroxyl groups of substrate/product analogues. Second, in mouse SMP30/GNL, a lid loop covering the substrate-binding cavity seems to hamper the binding of L-gulonate in an extended (or all-trans) conformation; L-gulonate seems to bind to the active site in a folded conformation. In contrast, the substrate-binding cavities of the other related enzymes are open to the solvent and do not have a cover. This structural feature of mouse SMP30/GNL seems to facilitate the γ-lactone-ring formation.


Subject(s)
Ascorbic Acid/biosynthesis , Ascorbic Acid/chemistry , Calcium-Binding Proteins/metabolism , Carboxylic Ester Hydrolases/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Lactones/chemistry , Lactones/metabolism , Animals , Calcium-Binding Proteins/chemistry , Carboxylic Ester Hydrolases/chemistry , Cations, Divalent/metabolism , Crystallography, X-Ray , Glucose/metabolism , Humans , Intracellular Signaling Peptides and Proteins/chemistry , Mice , Models, Molecular , Protein Conformation , Xylitol/metabolism
4.
Biol Pharm Bull ; 34(11): 1744-7, 2011.
Article in English | MEDLINE | ID: mdl-22040889

ABSTRACT

It has been suggested that some food components, such as bioflavonoids, affect the bioavailability of ascorbic acid in humans. Since little is known in Japan about the effective intake of this dietary requirement, we tested young Japanese males after the ingestion of commercial ascorbic acid or acerola (Malpighia emarginata DC.) juice to compare the quantities absorbed and excreted. Healthy Japanese subjects received a single oral dose of ascorbic acid solution (50, 100, 200 or 500 mg) and received distilled water as a reference at intervals of 14 d or longer. All subjects were collected blood and urine until 6 h after ingestion and evaluated for time-dependent changes in plasma and urinary ascorbic acid levels. Predictably, the area under the curve (AUC) values in plasma and urine after ingestion increased dose-dependently. Next, each subject received diluted acerola juice containing 50 mg ascorbic acid. Likewise, their plasma and urinary ascorbic acid concentrations were measured. In plasma, the AUC value of ascorbic acid after ingestion of acerola juice tended to be higher than that from ascorbic acid alone. In contrast, the urinary excretion of ascorbic acid at 1, 2 and 5 h after ingestion of acerola juice were significantly less than that of ascorbic acid. These results indicate that some component of acerola juice favorably affected the absorption and excretion of ascorbic acid.


Subject(s)
Ascorbic Acid/pharmacokinetics , Food-Drug Interactions , Fruit/chemistry , Intestinal Absorption , Malpighiaceae/chemistry , Plant Preparations/pharmacology , Vitamins/pharmacokinetics , Adult , Area Under Curve , Ascorbic Acid/blood , Ascorbic Acid/urine , Beverages , Dose-Response Relationship, Drug , Flavonoids/pharmacology , Humans , Japan , Male , Plant Preparations/chemistry , Reference Values , Vitamins/blood , Vitamins/urine , Young Adult
5.
Biochem Biophys Res Commun ; 377(1): 291-6, 2008 Dec 05.
Article in English | MEDLINE | ID: mdl-18848523

ABSTRACT

Vitamin C (VC) has a strong antioxidant function evident as its ability to scavenge superoxide radicals in vitro. We verified that this property actually exists in vivo by using a real-time imaging system in which Lucigenin is the chemiluminescent probe for detecting superoxide in senescence marker protein-30 (SMP30)/gluconolactonase (GNL) knockout (KO) mice, which cannot synthesize VC in vivo. SMP30/GNL KO mice were given 1.5 g/L VC [VC(+)] for 2, 4, or 8 weeks or denied VC [VC(-)]. At 4 and 8 weeks, VC levels in brains from VC(-) KO mice were <6% of that in VC(+) KO mice. Accordingly, superoxide-dependent chemiluminescence levels determined by ischemia-reperfusion at the 4- and 8 weeks test intervals were 3.0-fold and 2.1-fold higher, respectively, in VC(-) KO mice than in VC(+) KO mice. However, total superoxide dismutase activity and protein levels were not altered. Thus, VC depletion specifically increased superoxide generation in a model of the living brain.


Subject(s)
Antioxidants/metabolism , Ascorbic Acid/genetics , Brain/metabolism , Superoxides/metabolism , Acridines/analysis , Acridines/metabolism , Animals , Ascorbic Acid/metabolism , Body Weight , Calcium-Binding Proteins/genetics , Carboxylic Ester Hydrolases/genetics , Intracellular Signaling Peptides and Proteins/genetics , Luminescent Agents/analysis , Luminescent Agents/metabolism , Mice , Mice, Knockout , Superoxides/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...